Our Curious Amalgam

Toggle navigation
  • About
  • Hosts
  • Gallery
  • Episodes
  • ABA
  • Search

#114 What Are the Generic and Biosimilar Industries Worried About? Current Competition Law Issues Impacting the Sector.

https://ourcuriousamalgam.com/episode-player/1723/114-generic-biosimilar-industries-current-competition-law-issues-impacting-sector.mp3?stats-code=ocaPodcastSite
Adrian van den Hoven, Director General, Medicines for Europe

Generics and biosimilars are an important part of the pharmaceutical landscape in Europe. What are the competition law issues faced by suppliers of those products? Adrian van den Hoven, Director General of trade association Medicines for Europe, joins John Roberti and Matthew Hall to discuss the key concerns of generic and biosimilar suppliers and also the dramatic impact of COVID-19 on them. Listen to this episode to learn more about the application of competition law to pharmaceuticals and the background to the 2020 comfort letter granted by the European Commission at the request of Medicines for Europe.

Adrian van den Hoven, Director General, Medicines for Europe

Related Links:

Medicines for Europe White Paper on Barriers to Generic and Biosimilar Market Entry

Medicines for Europe Paper on Patent Linkage

Medicines for Europe Paper on Divisional Patents

Hosted by:

John Roberti, Partner, Allen & Overy and Matthew Hall, Partner, McGuireWoods London LLP


Posted On May 10, 2021

Posted By Our Curious Amalgam

Posted In Europe FOREIGN JURISDICTIONS

Tagged biosimilars comfort letter COVID denigration divisional patents European Commission generics patent linkage pharmaceuticals

Share


Prev

#113 Are “UDAPs” Protecting Consumers or Promoting Chaos? Exposing the Fault Lines under State Statutes Prohibiting Unfair and Deceptive Acts and Practices

Next

#115 Are We Witnessing a Revolution? Putting the Debate Over Antitrust Reform Into Context.

Scroll to the top

Don't miss new episodes every Monday. Subscribe now!

Our Curious Amalgam explores topics in antitrust, competition, consumer protection, data protection, and privacy law around the world with leading experts in those areas. It is an amalgam because it is a group of diverse topics all in one place. It is curious because it gets the experts and asks them in-depth questions.

© 2019-2023 American Bar Association. All Rights Reserved.

NEWS AND EVENTS
What's Going on at the Antitrust Law Section

CONTACT US
podcast@ourcuriousamalgam.com

Find us on social!

Facebook Twitter Instagram LinkedIn RSS Feed

Subscribe
Subscribe on iTunes
Listen on Spotify
Listen on Google Podcasts
Listen to Stitcher
Amazon music
The opinions expressed by the participants in the podcasts are their own and do not necessarily represent those of their employers or other affiliated organizations.